Your perfect In-licensing and Product Development partner
- Global licensing is our strength & we have a strong research team who identifies niche,novel formulations developed at international markets of USA, Europe, UK, Australia etc with extensive clinical support.
- We at MORSEF continues to explore market opportunities through Product Development, Incremental innovation & licensing arrangements and alliances to draw maximum value from such arrangements. For marketing alliances, we work on non-infringement policies that respect the intellectual property rights of its partners
Out Licensing & International Business:
- Our forte in Out-licensing extends worldwide which enables us to provide good quality
products to potential marketers who can justify our product and its USP. - Our services extend globally with exports to several regions like: Middle Eastern countries,
African countries, South-East Asian Countries and Latin American countries,
Oceania Countries etc. - We are open to explore potential export opportunities with new Partners for several new territories.
Morsef supplies general formulations as per customers specific requirement. Morsef also does Private Labeling Business. Morsef has a wide range of dosage forms including:
- Oral Liquid
- Tablets
- Capsules
External preparations such as:
- Lotions and Liniment
- Creams
- Ointments
- Powders
- Diagnostic Agents
- Dry Powder Suspension
Range of API ready to offer
- With a strong network with leading API manufacturers, we can offer a good quality product to potential buyers
depending on specifications & quality requirements. - With reliable and established links in various countries like India,U.S.A,Europe,China, Korea,etc.
Incremental Innovation Is what Drive Us
- Our research and development department carries out process development, formulation development and analytical research for our domestic and international markets.
- Strong techno managerial team with 30 years of Pharmaceuticals experience help us to drive innovation in the company
- We believe that our continuing research and development initiatives have strengthened our product offering in India and other international markets. We have a strong pipeline of products under development for our focus markets.
Mergers and Aquisitions
The number of mergers and acquisitions in the pharmaceutical industry has continued to rise with each passing year. Of these deals, the largest proportion were for diversified assets, meaning the acquired company is active in two or more core therapeutic areas, none of which predominate.
Companies focused in generics ,companies with broad portfolios, and some specialty pharmaceutical companies, which focus their portfolios on drugs for clinical specialties or grow by merging with or acquiring other specialty pharmaceutical companies.
Our M&A advisory team focuses on identifying strategic fits for our clients and enabling them to grow their business through the inorganic route by making acquisitions that provide access to newer markets, better technologies and innovative products and result in creating shareholder value. Our scope of services includes the following:
- Identifying and Approaching potential clients and establishing a working relationship with them
- Sourcing deals that make strategic sense to our clients
- Advising on Valuation and Documentation
- Transaction closure
- Post transaction support
